If your loved one with PWS struggles with daytime sleepiness, you may be interested in learning more about TEMPO, a phase 3 study of Pitolisant, now enrolling volunteers with PWS ages 6 to 65 years old. This study will evaluate the efficacy of Pitolisant in treating excessive daytime sleepiness in children and adults with PWS, as well as its efficacy in improving irritable and disruptive behaviors, hyperphagia, and other behavioral challenges.
A live webinar was conducted in June 2024, sharing details of the study, what you can expect if you choose to participate, and eligibility criteria for participation. The presentation is 20 minutes in length, followed by 10 minutes of Q&A. You can watch the complete presentation by clicking on the embedded video. In case you don't have time to watch the full video, we've included slides from the presentation below.
Please visit the TEMPO website for more information on this study.
